Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-02-12
DOI
10.1038/s41388-019-0737-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses
- (2018) Laura Menotti et al. Viruses-Basel
- A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors
- (2018) Valerio Leoni et al. PLoS Pathogens
- Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting
- (2018) Irene Appolloni et al. CANCER LETTERS
- Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation
- (2017) Rūta Veinalde et al. OncoImmunology
- Retargeting Strategies for Oncolytic Herpes Simplex Viruses
- (2016) Gabriella Campadelli-Fiume et al. Viruses-Basel
- IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice
- (2016) Eric D. Thomas et al. Journal of Ovarian Research
- Noninvasive Monitoring of Glioma Growth in the Mouse
- (2016) Francesco Alessandrini et al. Journal of Cancer
- Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
- (2016) Daxa M. Patel et al. Human Gene Therapy Clinical Development
- The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma
- (2015) Barbara Banelli et al. CELL CYCLE
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Manipulation of apoptosis and necroptosis signaling by herpesviruses
- (2015) Hongyan Guo et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Revisiting the Mechanisms of CNS Immune Privilege
- (2015) Antoine Louveau et al. TRENDS IN IMMUNOLOGY
- From virotherapy to oncolytic immunotherapy: where are we now?
- (2015) Robert S Coffin Current Opinion in Virology
- Sox2 Is Required to Maintain Cancer Stem Cells in a Mouse Model of High-Grade Oligodendroglioma
- (2014) Rebecca Favaro et al. CANCER RESEARCH
- Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model
- (2013) T. A. Cheema et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of HER2 retargeted herpes simplex virus as therapy for high-grade glioma in immunocompetent mice
- (2012) E Reisoli et al. CANCER GENE THERAPY
- Replication-competent Herpes Simplex Virus Retargeted to HER2 as Therapy for High-grade Glioma
- (2012) Eleonora Gambini et al. MOLECULAR THERAPY
- Effective Treatment of an Orthotopic Xenograft Model of Human Glioblastoma Using an EGFR-retargeted Oncolytic Herpes Simplex Virus
- (2012) Hiroaki Uchida et al. MOLECULAR THERAPY
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
- (2011) Sebastian F. M. Häusler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Rethinking herpes simplex virus: the way to oncolytic agents
- (2011) Gabriella Campadelli-Fiume et al. REVIEWS IN MEDICAL VIROLOGY
- A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer
- (2010) A Nakao et al. CANCER GENE THERAPY
- HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
- (2010) N. Ahmed et al. CLINICAL CANCER RESEARCH
- Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas
- (2010) Sasha Gulati et al. Diagnostic Pathology
- Differential Distribution of erbB Receptors in Human Glioblastoma Multiforme: Expression of erbB3 in CD133-Positive Putative Cancer Stem Cells
- (2010) Véronique Duhem-Tonnelle et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Construction of a Fully Retargeted Herpes Simplex Virus 1 Recombinant Capable of Entering Cells Solely via Human Epidermal Growth Factor Receptor 2
- (2008) L. Menotti et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now